|
CHSY1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.4432899320127E-15 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.93856042329799E-12 |
| Normal-vs-Stage2 |
5.5018999999934E-05 |
| Normal-vs-Stage3 |
1.97799998602477E-10 |
| Normal-vs-Stage4 |
9.38320000032355E-07 |
| Stage1-vs-Stage2 |
9.377800E-01 |
| Stage1-vs-Stage3 |
4.567400E-01 |
| Stage1-vs-Stage4 |
4.185600E-01 |
| Stage2-vs-Stage3 |
6.112600E-01 |
| Stage2-vs-Stage4 |
4.924000E-01 |
| Stage3-vs-Stage4 |
7.726800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.7715611723761E-16 |
| Normal-vs-AfricanAmerican |
2.375800E-03 |
| Normal-vs-Asian |
9.135000E-03 |
| Caucasian-vs-AfricanAmerican |
4.136000E-01 |
| Caucasian-vs-Asian |
7.043000E-01 |
| AfricanAmerican-vs-Asian |
9.947200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.85140791586491E-12 |
| Normal-vs-Female |
1.37909683672888E-11 |
| Male-vs-Female |
1.080840E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.363300E-03 |
| Normal-vs-Age(41-60Yrs) |
4.96080954093259E-12 |
| Normal-vs-Age(61-80Yrs) |
1.7803536422889E-12 |
| Normal-vs-Age(81-100Yrs) |
1.042250E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.701200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.660800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.232000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.917800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.456190E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.680000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.680000E-03 |
| Normal-vs-Grade 2 |
2.83106871279415E-14 |
| Normal-vs-Grade 3 |
5.30169996793006E-09 |
| Normal-vs-Grade 4 |
7.13320003065121E-09 |
| Grade 1-vs-Grade 2 |
4.663800E-01 |
| Grade 1-vs-Grade 3 |
6.958400E-02 |
| Grade 1-vs-Grade 4 |
1.947020E-01 |
| Grade 2-vs-Grade 3 |
8.175100E-04 |
| Grade 2-vs-Grade 4 |
4.502800E-01 |
| Grade 3-vs-Grade 4 |
3.035700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.88178419700125E-16 |
| Normal-vs-ccB subtype |
2.61760002562283E-09 |
| ccA subtype-vs-ccB subtype |
7.723400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.07850411829236E-11 |
| Normal-vs-N1 |
1.751750E-02 |
| N0-vs-N1 |
9.597600E-01 |
|
|
